SAFETY AND EFFICACY OF THE ANTI-TISSUE FACTOR PATHWAY INHIBITOR MARSTACIMAB IN PARTICIPANTS WITH SEVERE HEMOPHILIA WITHOUT INHIBITORS: RESULTS FROM THE PHASE 3 BASIS TRIAL AND ONGOING LONG-TERM EXTENSION STUDY

被引：0

作者：

Acharya, Suchitra S. ^{[1
]}

Matino, Davide ^{[2
]}

Palladino, Andrew ^{[3
]}

Hwang, Eunhee ^{[3
]}

McDonald, Regina ^{[4
]}

Taylor, Carrie Turich ^{[5
]}

Teeter, John ^{[5
]}

机构：

[1] Northwell Hlth, Northwell Hemostasis & Thrombosis Ctr, Cohen Childrens Med Ctr, New Hyde Pk, NY USA

[2] McMaster Univ, 237 Barton St East, Hamilton, ON, Canada

[3] Pfizer Inc, Collegeville, PA USA

[4] Pfizer Inc, New York, NY USA

[5] Pfizer Inc, Groton, CT USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2024年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4 / 4

页数：1

共 50 条

[31] Long-term efficacy, safety, and adherence to tralokinumab treatment in moderate-to-severe atopic dermatitis for up to 3 years: Interim readout of ECZTEND, a phase 3, long-term extension trial
Blauvelt, Andrew
Lacour, Jean-Philippe
Toth, Darryl
Laquer, Vivian
Beissert, Stefan
Wollenberg, Andreas
Herranz, Pedro
Pink, Andrew
Peris, Ketty
Saeki, Hidehisa
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB159 - AB159
[32] Long-Term Safety and Efficacy of Risankizumab Treatment in Patients With Crohn's Disease: 3-Year Interim Results From the Ongoing Phase 2 Open-Label Extension Study
Ferrante, Marc
Feagan, Brian G.
Panes, Julian
Baert, Filip
Louis, Edouard
Dewit, Olivier
Kaser, Arthur
Duan, Weijiang
Gustafson, Dawn
Liao, Xiaomei
Wallace, Kori
Kalabic, Jasmina
D'Haens, Geert R.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S466 - S466
[33] Safety and Longer-Term Efficacy of Concizumab Prophylaxis in Patients with Hemophilia a or b with Inhibitors: Results from the Extension Part of the Phase 2 explorer4 Trial
Shapiro, Amy D.
Castaman, Giancarlo
Cepo, Katarina
Tonder, Sidsel Marie
Matsushita, Tadashi
Poulsen, Lone Hvitfeldt
Young, Guy
Zupancic-Salek, Silva
Yuste, Victor Jimenez
BLOOD, 2020, 136
[34] LONG-TERM OUTCOMES WITH EMICIZUMAB PROPHYLAXIS FOR SEVERE HAEMOPHILIA A WITHOUT FVIII INHIBITORS: EFFICACY AND SAFETY ANALYSES FROM HAVEN 3 & 4
Mahlangu, J.
Jimenez-Yuste, V.
Ventriglia, G.
Niggli, M.
Barlera, S.
Hermans, C.
Lehle, M.
Chowdary, P.
Jew, L.
Windyga, J.
Frenzel, L.
Castaman, G.
Pipe, S. W.
HAEMOPHILIA, 2023, 29 : 95 - 96
[35] Long-Term Safety and Efficacy of Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Previously Treated Pediatric Patients with Hemophilia B: Results from a Phase 3b Extension Study
Kenet, Gili
Chambost, Herve
Male, Christoph
Halimeh, Susan
Lambert, Thierry
Li, Yanyan
Seifert, Wilfried
Santagostino, Elena
THROMBOSIS AND HAEMOSTASIS, 2020, 120 (04) : 599 - 606
[36] Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial
Lentz, Steven R.
Janic, Dragana
Kavakli, Kaan
Miljic, Predrag
Oldenburg, Johannes
Ozelo, Margareth C.
Santagostino, Elena
Suzuki, Takashi
Salek, Silva Zupancic
Korsholm, Lars
Matytsina, Irina
Tiede, Andreas
HAEMOPHILIA, 2018, 24 (06) : E391 - E394
[37] Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial
Kimball, Alexa B.
Bechara, Falk G.
Badat, Aysha
Giamarellos-Bourboulis, Evangelos J.
Gottlieb, Alice B.
Jemec, Gregor B. E.
Reguiai, Ziad
Villani, Axel P.
Alarcon, Ivette
Bansal, Amita
Gasperoni, Francesca
Martin, Ruvie
Paguet, Bertrand
Uhlmann, Lorenz
Zouater, Hichem
Ravichandran, Shoba
Alavi, Afsaneh
BRITISH JOURNAL OF DERMATOLOGY, 2025, 192 (04) : 629 - 640
[38] Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial
Jeyaratnam, Jerold
Simon, Anna
Calvo, Inmaculada
Constantin, Tamas
Shcherbina, Anna
Hofer, Michael
Gattorno, Marco
Martini, Alberto
Bader-Meunier, Brigitte
Vastert, Bas
Levy, Jeremy
Dekker, Elise
de Benedetti, Fabrizio
Frenkel, Joost
RHEUMATOLOGY, 2022, 61 (05) : 2088 - 2094
[39] Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial
Szeimies, Rolf-Markus
Abels, Christoph
Kilic, Ana
Reich, Hubert
Berger, Birgit
zur Wiesche, Erik Schulze
Schramm, Katharina
Litzka, Leonie
Heimstaedt-Muskett, Susanne
Masur, Clarissa
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (04) : 823 - 830
[40] Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study
Stephan Petersenn
Andrew J. Farrall
Christophe Block
Shlomo Melmed
Jochen Schopohl
Philippe Caron
Ross Cuneo
David Kleinberg
Annamaria Colao
Matthieu Ruffin
Karina Hermosillo Reséndiz
Gareth Hughes
Ke Hu
Ariel Barkan
Pituitary, 2014, 17 : 132 - 140

← 1 2 3 4 5 →